Drug profile · INN
desirudin
REVASC
desirudin (REVASC) is a thrombin inhibitor.
EMA: withdrawn Blood and blood forming organs (B01) B01AE01
Patents linked 2
Pipeline programs 1
News articles 0
Drug details — desirudin
- Class
- Blood and blood forming organs (B01)
- Route
- —
- Patents
- 2
- Programs
- 1
- Data quality
- 0.83
Quick answer
desirudin (REVASC) is a thrombin inhibitor.
Key facts
INN desirudin
Brand REVASC
Mechanism Thrombin inhibitor
Target Prothrombin
Therapeutic class Blood and blood forming organs (B01)
ATC code B01AE01
Mechanism of action
Thrombin inhibitor
Primary target: Prothrombin
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is desirudin?
desirudin (REVASC) is a thrombin inhibitor.
What is the brand name for desirudin?
REVASC is a marketed brand name for desirudin. Check FDA Drugs@FDA for the current US label holder and prescribing information.